Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s Experience
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s Experience
Authors
Keywords
Pulmonary Metastasis, Survivin Expression, Trabectedin, Mitotic Count, Distant Metastatic Disease
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 20, Issue 7, Pages 2364-2372
Publisher
Springer Nature
Online
2013-01-19
DOI
10.1245/s10434-012-2834-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Therapeutic Targets in Soft Tissue Sarcoma
- (2012) Elizabeth G. Demicco et al. ADVANCES IN ANATOMIC PATHOLOGY
- Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma
- (2012) K. J. Brewer Savannah et al. CLINICAL CANCER RESEARCH
- Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis
- (2012) Mario M. Leitao et al. GYNECOLOGIC ONCOLOGY
- Histopathologic Prognostic Factors in Stage I Leiomyosarcoma of the Uterus
- (2011) Wei-Lien Wang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Repeated and Aggressive Pulmonary Resections for Leiomyosarcoma Metastases Extends Survival
- (2011) Bryan M. Burt et al. ANNALS OF THORACIC SURGERY
- Prognostic factors in uterine sarcoma
- (2011) Angiolo Gadducci BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia
- (2011) H.J. Mackay et al. GYNECOLOGIC ONCOLOGY
- p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
- (2011) C Romagosa et al. ONCOGENE
- Prognostic Factors and Outcomes in 28 Cases of Uterine Leiomyosarcoma
- (2011) V. Loizzi et al. ONCOLOGY
- Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas
- (2010) Martee L Hensley CURRENT OPINION IN ONCOLOGY
- Expression of E-cadherin, β-catenin and topoisomerase IIα in leiomyosarcomas
- (2009) Pinelopi N. Gogou et al. Clinical & Translational Oncology
- β-Catenin expression in uterine sarcomas and its relation to clinicopathological parameters
- (2009) Wanja Kildal et al. EUROPEAN JOURNAL OF CANCER
- Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: Inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma
- (2009) C.-F. Gao et al. MOLECULAR CANCER THERAPEUTICS
- Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors
- (2008) Alexander J.F. Lazar et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas
- (2008) Daniel S. Kapp et al. CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started